Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase EARLY_PHASE1 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2

Conditions

Neoplasms 4Barrett Esophagus 4Uterine Cervical Neoplasms 2Uterine Cervical Dysplasia 2Mouth Neoplasms 2Uterine Neoplasms 1Oral Lesions 1Neoplasms, Squamous Cell 1Mouth Diseases 1Malignant Neoplasms of Female Genital Organs 1Laryngeal Diseases 1Head and Neck Neoplasms 1Gastroesophageal Reflux 1Endometrial Neoplasms 1Colonic Polyps 1Carcinoma, Squamous Cell 1Carcinoma in Situ 1

Interventions

Cisplatin 176Paclitaxel 79Radiotherapy 76Carboplatin 70Brachytherapy 69pembrolizumab 63Bevacizumab 40Gemcitabine 28Radiation 27Topotecan 26Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 25Nivolumab 22Colposcopy 22human papillomavirus vaccine, L1 type 16, 18 21Magnetic Resonance Spectroscopy 21atezolizumab 19Platinum 19Drug Therapy 19Papillomavirus Vaccines 18Radiotherapy, Intensity-Modulated 17Docetaxel 17Taxes 16Cyclophosphamide 16Biopsy 16Early Intervention, Educational 151,2-diaminocyclohexaneplatinum II citrate 15Methods 14Blood Specimen Collection 14fludarabine 13Injections 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Uterine Cervical Neoplasms × Proflavine × Clear all
NCT02206048 2022-07-25

Use of High-Resolution Microendoscopy (HRME) in Patients With Adenocarcinoma In-Situ (AIS) of the Cervix

M.D. Anderson Cancer Center

Phase NA Completed
9 enrolled 5 charts
Gynecologic

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT02420665 2021-05-28

Use of High-Resolution Microendoscopy (HRME) in Patients With Cervical Dysplasia

M.D. Anderson Cancer Center

Phase EARLY_PHASE1 Completed
50 enrolled
Gynecologic

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡